top of page
V2V ZONE

UNMET PATIENT NEED

Cuttsy+Cuttsy: Cocreation of resources to support treatment decisions

Activation of patient voice

average rating is 2.5 out of 5, based on 2 votes, Ratings

Behavioural change

average rating is 2.5 out of 5, based on 2 votes, Ratings

Collaboration

average rating is 4.5 out of 5, based on 2 votes, Ratings

Overall Impact

average rating is 4 out of 5, based on 2 votes, Ratings

As experts in creative healthcare communications, we make complex information understandable, accessible and actionable for patients.

Everything we do is underpinned by the patient voice, gathered through advocacy group partnerships, focus groups, and many other tactics. This feeds into what we create, and how we share it.

We’re incredibly proud of our success stories to date, including:

  • New ways to empower dialogue between patients and healthcare teams

  • Working with patients with accessibility barriers to create materials that meet their needs

  • Improving the informed consent process to ensure patients are truly informed during clinical trials

  • Helping patients recognise, report, and cope with treatment side effects

In our V2V case study, we’ll share how we worked with patients to co-create a suite of materials that would help them and their loved ones understand a new type of cancer therapy, and make treatment choices that were right for them.

We’d love to hear your thoughts!

Rate this presentation
Acitivation of Patient Voice
Behavioural change
Collaboration
Overall Impact
Comments (5)

Cathy Sertori
18 de nov. de 2024

Great to see a global approach. Is / was the tool kit able to be adapted for specifical local needs / requirements?

Like
Caroline Benson
19 de nov. de 2024
Respondendo a

The toolkit was adapted at a local level and rolled out with support from the global team.

Like

Olivia Kersey
Olivia Kersey
Admin
30 de jan.
Respondendo a

Great! Any particular tips or lessons learned re. Global to Local adaptation and rollout?

Like

Emma Sutcliffe
Emma Sutcliffe
Admin
14 de nov. de 2024

I'm longing to know 'who' the pharma sponsor is so I can congratulate them for sponsoring this important health education and literacy work. Truly this is an 'all in' approach. Even as a Medical Biochemist with 25y working in pharma, all info about immunotherapy is incredibly complex so to align so many patients from so many different countries and create resources that work for the many not the few is admirable. Great work.

Like

Michelle Warner
Michelle Warner
14 de nov. de 2024

Another excellent example of a pharma company truly listening, not just to patients but also to those who care for them, including healthcare professionals. The development of educational materials created with the patient community is a clear step forwards, has this translated into a greater acceptance of IO therapies by patients / carers? If that behaviour change could be included as a 'look ahead' it is likely to successfully illustrate the importance of this work to others. The biggest challenge is going to be pharma company commitment (i.e. people and budget) to maintain and build on this partnership and to continue to address the needs of their patient community.

Like

Sponsored by

sponsors_0000_zebricks.png
sponsors_0003_life.png
sponsors_0000_zebricks.png
sponsors_0005_Cuttsy.png
sponsors_0000_zebricks.png
sponsors-intent.png
sponsors_0000_zebricks.png
sponsors_0002_Medscape_Logo.png
sponsors_0000_zebricks.png
sponsors-open-health.png
sponsors_0000_zebricks.png
sponsors_0000_zebricks.png
sponsors_0000_zebricks.png
sponsors-ZS.png
bottom of page